| AIM Snapshot | |
|---|---|
| AIM ImmunoTech Inc., an immunpharmaceutical company, focuses on research and development of therapies to treat multiple types of cancers, viruses, and immunodeficiency disorders in the United States. The company is headquartered in Ocala, Florida. | |
| VALUATION DATA | |
| Market Capitalization | $21,315,800 | Price to Sales | 0.00 |
| Earnings per Share | $-0.6000 |
| PE Ratio | None |
| PRICE DATA | |
| Most Recent Close | $0.4200 |
| 52 Week High | $138.83 |
| 52 Week Low | $2.938 |
| 50-Day Moving Average | $81.1 |
| 200-Day Moving Average | $-0.517 |
| All data are from Alpha Vantage as of today. For more infomation on AIM see Stock Dividend, Valuation, Price and Financial Data for Investors | |
Custom Search